Isoray - Innovative Brachytherapy
International Journal of Radiation Oncology Biology Physics
Early Outcomes of Prostate Seed Implants with 131Cs: Toxicity and Initial PSA Dynamics from a Single Institution
Authors: C.S. Platta, D. Khuntia, J. Adkinson, E. Olson, S. Jennifer, H. Odau, R.R. Patel
Published: 01/09/2008

“Cesium provides everything we want for prostate brachytherapy as both a monotherapy and in combination therapy, including delivery of a high dose of radiation more quickly for high risk patients in a low dose rate ‘setting.’” 

Dr. Bernard W. Taylor, MD

Texas Oncology - Longview Cancer Center